Skip to content

Daewoong Pharmaceutical Co Ltd Sustainability Reports

Daewoong Pharmaceutical Co., Ltd. develops, manufactures, and commercializes prescription and over-the-counter pharmaceutical products. Its major treatments focus on metabolic, cardiovascular, gastrointestinal, and central nervous system diseases, alongside botulinum toxin products.

Sector: Manufacturing

Country: South Korea

Exchange: Korea Exchange (KOSPI)

ISIN: KR7069620003

7 reports from 2021 to 2025